An adiponectin variant with one or more amino acid modifications relative to a corresponding parent adiponectin, wherein the solubility of the variant is improved by at least 3-fold relative to residues 110-244 of human adiponectin.

 
Web www.patentalert.com

< ActRII receptor polypeptides, methods and compositions

< Heterocyclic GPR40 modulators

> Control of treatment therapy during start-up and during operation of a medical device system

> Nitrogen-containing fused heterocyclic compounds
~ 00603